Abstract
P-glycoprotein (P-gp) inhibitors, like zosuquidar, partly increase oral bioavailability of P-gp substrates, such as etoposide. Here, it was hypothesis......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
